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Abstract
Background: Little is known about practices used to disseminate findings to non-research, practitioner audiences. This study describes the perspectives, experience and activities of dissemination & implementation (D&I) scientists around disseminating their research findings.
Methods: The study explored D&I scientists’ experiences and recommendations for assessment
of dissemination activities to non-research audiences. Existing list serves were used to recruit
scientists. Respondents were asked three open-ended questions on an Internet survey about
dissemination activities, recommendations for changing evaluation systems and suggestions
to improve their own dissemination of their work. Results: Surveys were completed by 159 scientists reporting some training, funding and/or publication history in D&I. Three themes
emerged across each of the three open-ended questions. Question 1 on evaluation generated
the themes of: 1a) promotional review; 1b) funding requirements and 1c) lack of acknowledgement of dissemination activities. Question 2 on recommended changes generated the themes of:
2a) dissemination as a requirement of the academic promotion process; 2b) requirement of
dissemination plan and 2c) dissemination metrics. Question 3 on personal changes to improve
dissemination generated the themes of: 3a) allocation of resources for dissemination activities;
3b) emerging dissemination channels and 3c) identify and address issues of priority for stakeholders. Conclusions: Our findings revealed different types of issues D&I scientists encounter
when disseminating findings to clinical, public health or policy audiences and their suggestions
to improve the process. Future research should consider key requirements which determine
academic promotion and grant funding as an opportunity to expand dissemination efforts.

Introduction
Timely translation of the benefits of health-related research is of international concern [1–3].
Both literature and policy assume that rapid translation of research into practice is ideal, yet
delays in the operationalisation of research findings into real world practice persist [1].
While some lag is anticipated to ensure the safety and efficacy of new interventions or medical
advances, we should aim to lessen the frequently cited 17-year lag time for 14% of evidence to
reach practice [4,5]. Delays are seen as a waste of limited resources and an expense of potential
patient benefit; however, research investigating factors which affect how scientist disseminate
health research outside of the academic setting (e.g., to non-research clinical and policymaker
audiences) is relatively scant [6].
Previous studies investigating the variety of dissemination practices to non-research audiences are limited. One study examined dissemination practices among public health scientists
to identify factors related to dissemination efforts to public health officials. Study results found
one-third of scientists rated their dissemination efforts as poor. However, many factors were
significantly related to whether a researcher rated him/herself as excellent/good, including obligation to disseminate findings, importance of dissemination to his/her academic department
and expectations by employer or by funder. Still, it is unclear how dissemination practices
are integrated to annual performance metrics or funding mechanisms [7]. Further, prior work
did not extensively assess perceived or existent requirements to disseminate findings to nonacademic stakeholders. A greater understanding of these issues will illustrate the actual
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experience of scientists as they attempt to disseminate findings to
non-research audiences while navigating an academic career and
being responsive to requirements by grant funders.
A recent study by Knoepke et al. characterised current practices
of dissemination to these audiences among dissemination and
implementation (D&I) scientists [8]. More specifically, the study
investigated potential characteristics associated with greater use
of various dissemination strategies. While scientists were from
diverse settings (e.g., clinical and community) and routinely
engaged in a variety of dissemination-related activities, there were
noticeable differences in the dissemination strategies used between
scientists. These findings suggest additional factors related to academic setting or funding requirements may influence dissemination-related activities.
To further explore factors related to use of dissemination strategies meant to improve uptake of research findings in clinical and
public practice among D&I scientists, the current project conducted an analysis of the qualitative responses of a previouslyreported survey of D&I scientists [8]. The aims of this analysis
are to: summarise D&I scientists’ experiences and opinions regarding dissemination activities’ importance to their work; identify
how they are evaluated in this area of D&I science and summarise
suggestions for how to improve the process to enhance translation
to practice.

McNeal et al.

evaluated?, 2) how would you improve the system for credit or recognition for disseminating research to non-research audiences? and
3) what is the one thing you could do that would most enhance your
efforts to disseminate your research to non-research audiences?
Data Analyses
The qualitative responses were transcribed verbatim into a word
processing document. Qualitative responses were analysed by the primary authors (DMM, CEK), using a collaborative inductive open coding process for content analysis [9]. Both authors are PhD-trained
researchers with experience in qualitative methods, health services
research and D&I science. The analysis was conducted using inductive
reasoning across three stages: 1) independent open coding followed by
discussion of code descriptions to achieve consensus; 2) independent
aggregation of codes into categories followed by discussion to reach
consensus, development of category descriptions and identification of
exemplars; 3) independent analysis followed by discussion to identify
and describe overall themes, with categories across open-ended items
examined for overlap, and to maintain objectivity. The project team
reviewed and agreed upon key themes that emerged from the qualitative data. Thematic saturation was achieved as further observations
and analysis revealed no new themes [10,11].
Results

Materials and Methods
Sample and Procedures
Sample identification and online survey administration methods, as
well as return characteristics of the dataset being analysed have been
previously described [8]. In brief, we purposively sampled the opinions and insights of scientists with interest, training, funding and/or
publication history in D&I. The survey asked respondents to report
practices related to dissemination of findings to non-research audiences, as well as described methods by which they engage stakeholders in research to enhance translation. The project was approved by
the Colorado Combined Institutional Review Board (COMIRB),
including a waiver of written consent to participate.

Demographic characteristics of surveyed scientists are presented in
Table 1. Of the 159 scientist who completed the survey, all provided
qualitative responses to at least one of the three open-response
items. Specifically, we received 95 responses for questions 1 and
2 and 159 responses from question 3. The majority of scientists
were from university or research settings in the USA (69%) or
Canada (13%). They were from a mix of clinical (33%) and community settings (68%). The majority were from behavioural health
(43%) or public health disciplines (42%); 26% had received formal
training in D&I and there was a wide distribution in years since
highest academic degree.
What follows are reports of key themes present in the data
organised by each of the open-ended question. Additional illustrative quotes are also provided in Tables 1–3.

Data Collection
Surveys were distributed through Qualtrics® (when individual
email addresses were available) or through electronic listservs as
appropriate. Listserv distributions were conducted by managers
of those listservs rather than by our study personnel due to confidentiality requirements. Potential scientists for whom we had individual email addresses received up to three reminder emails at
1-week intervals from April to May 2018. Responses were collected
anonymously and respondents did not receive any incentive for
participation.
The recent Knoepke et al. publication reports quantitative results
of the survey regarding D&I scientists’ use of different dissemination
strategies [8]. While the level of effort devoted to stakeholder
engagement and non-academic dissemination appears to have
increased over time, participants reported that the primary dissemination venues continued to be academic publications, conference
presentations and reports to funders [7,8]. This difference persists
despite a belief among D&I scientists that workshops, policy, briefs
and face-to-face meetings are more effective channels for affecting
practice or policy [8]. The focus of this paper is on the separate but
related issue of responses to three open-ended questions: 1) how is
your dissemination of research findings to non-research audiences
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Question 1: How is Your Dissemination of Research Findings
to Non-research Audiences Evaluated?
Of the 95 responses to this question, three distinct themes emerged
from question 1: 1a) promotional review; 1b) funding requirements and 1c) lack of acknowledgement of dissemination
activities.
1a) Promotional review
Many respondents reported that when the dissemination of research
findings to non-research audiences was evaluated, this evaluation
occurred during an annual review. Researchers expressed a combination of ways in which the review took place. “When going up for
promotion or other awards we indicate the impact our work has
made on practice/policy. I also share events (i.e. policy changes) with
my leadership through email.” It was also expressed that the evaluation of dissemination activities is considered under the “broad
umbrella of community service.” Additionally, it was noted that
evaluation of dissemination often occurred only “qualitatively” during the performance review conversation, perhaps indicating that
these activities garnered less attention than more easily-quantifiable
productivity.
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Table 1. Sample quotes from question 1: how is your dissemination of research findings to non-research audiences evaluated?
Themes

Sample quotes

Theme 1a: promotional review

“As part of promotion as a ‘service.’”
“Based on reporting it in my annual faculty evaluation.”
“Annual impact statement as part of annual review.”
“It is part of the selection criteria used in the grant proposals that fund our work.”

Theme 1b: funding requirements

“By successful grants specifically for dissemination.”
“Annual report of the research institute.”
Theme 1c: lack of acknowledgement of dissemination activities

“It is actually not really evaluated. It is sort of a side note in our giant dossiers.”
“It is an important part of my job, but evaluated fairly subjectively.”

Table 2. Sample quotes from question 2: how would you improve the system for credit or recognition for disseminating research to non-research audiences?
Themes

Sample quotes

Theme 2a: dissemination as a requirement of the
academic promotion process

“Make it more desirable to reach these audiences (more recognition within formal reports etc. – not
everything should be based on publications).”
“If it became a requirement, I think that would naturally result in some type of recognition in yearly
evaluations, resulting in ‘credit’ of some type.”
“Make it a separate item (rather than within service to the community) when evaluating career
advancement (e.g., tenure, promotion, etc.).”

Theme 2b: requirement of dissemination plan

“Universities include in promotion, journals include in manuscripts, funders include in grant applications.”
“Incorporate it into promotion and tenure guidelines for academic appointments and in consideration
for VA promotion to GS14 status for investigators and increase amount of grant funding to pay for
this.”

Theme 2c: dissemination metrics

“Having a clear definition of what dissemination to such an audience entails, and accordingly using it
by the party giving that credit. The answer is hard to give as it also depends on who is giving the
credit.”
“First, you have to crack the measurement nut. In the same way that the coin of the research dissemination realm is number of publications, citations and journal impact factor, some equivalent,
reliable and valid assessment of impact needs to be developed. Assuming such a metric exists or is
developed then the next step needs to be working with the leadership to get them to see and accept
the value of such an assessment, as well as the value of this performance dimension in the overall
domain of performance for researchers.”

Table 3. Sample quotes from question 3: what is the one thing you could do that would most enhance your efforts to disseminate your research to non-research
audiences?
Themes
Theme 3a: allocation of resources for
dissemination activities
Theme 3b: emerging dissemination
channels

Sample quotes
“Better understanding of how to reach the audiences for scale-up.”
“Have a dedicated staff person for communication and dissemination support.”
“Visual abstracts for sharing on social media would likely garner more attention and interest – graphic design
and visuals are very helpful communication tools.”
“Produce lay summaries in patient facing research newsletters.”

Theme 3c: identify and address
issues of priority for stakeholders

“(Establish) advisory board engaged from proposal to dissemination.”
“Change the funding paradigm so it supports partnership and co-inquiry rather than single disease/time limited
projects. Change the focus to context, and what the context needs now/next.”

1b) Funding requirements
Overall, there was general agreement that many, but not all, grant
funders expected dissemination of research findings. Researchers
noted that “certain agencies specifically ask for this [dissemination]
in an annual report” and also have “explicit expectations for our
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activities of these programs in community.” Scientists reported that
particular funding agencies require “completion of milestones, presentation of results at meetings of various kinds” as well as the
“reporting of how stakeholders (including patients, caregivers,
policymakers, etc.) were engaged throughout the research process
as means of assuring the dissemination of research.”
1c) Lack of acknowledgement of dissemination activities
External evaluation of dissemination activities was often non-existent. A majority of researchers said that it is simply “not evaluated,”
as demonstrated by such statements as “it is not an important part
of my job.” Other respondents also noted they were either “unsure”
or “not certain” if the university requires such an evaluation. “My
institution only recognises peer-reviewed research in scholarly
journals; dissemination among practitioners or stakeholders is
derivative by an order of magnitude.” There were a modest number
of scientists that stated the information was recorded in the “CV
[curriculum vitae] section on dissemination” as well as through
“publications, citations, media, social media etc.” Table 1 presents
additional quotes of scientists’ experience with disseminating findings to non-research audiences.
Question 2: How Would You Improve the System for Credit or
Recognition for Disseminating Research to Non-research
Audiences?
Of the 95 responses to this question, three distinct themes emerged
from question 2: 2a) dissemination as a requirement of the academic
promotion process; 2b) requirement of dissemination plan and 2c)
dissemination metrics.
2a) Dissemination as a requirement of the academic
promotion process
Scientists described the need for a clear path for promotion that is
inclusive of metrics associated with disseminating research, noting
to “make it more desirable to reach these audiences (more recognition within formal reports etc. – not everything should be based
on publications).” Specific suggestions provided by researchers
were to “include it [dissemination] in metrics for academic promotion,” “recognition of practice-based reports equal to academic
journals” and “link to tenure process.”
2b) Requirement of dissemination plan
Scientists agreed in general that recognition for dissemination
activities would receive more attention if they were a required
element of grant proposals, noting to “add a dissemination outcome or plan in grant proposals; or a requirement to report dissemination channels and impact to non-research audiences : : : ”
Even more definitively, there were specific requests for “funders
require it” and that “NIH put more weight on it.” Researchers
more explicitly recommended to “make it [dissemination activities] a valued component of KT [knowledge translation] plans
on grant applications, include a section in manuscripts for other
ways to learn about the results of this study, assign higher priority
to these activities in Canadian Common CV/salary awards.”
2c) Dissemination metrics
Scientists generally believe that a clear measure to capture dissemination efforts will create a path for recognition within the academic setting. There was a general consensus that the current system lacks
metrics in place to evaluate dissemination, noting the need to
“develop a measure for how much time and effort a researcher puts
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into this, what the outcomes are, and make it as important as publishing in peer-reviewed journals.” Table 2 presents additional quotes of
scientists’ recommendations on ways to improve the system.
Question 3: What is the One Thing You Could do that Would
Most Enhance Your Efforts to Disseminate Your Research to
Non-research Audiences?
Of the 159 responses, three primary themes emerged from question 3: 3a) development of skills and allocation of resources for dissemination activities; 3b) emerging dissemination channels and
3c) identify and address issues of priority for stakeholders.
3a) Development of skills and allocation of resources for
dissemination activities
Scientists felt ill-equipped to effectively disseminate research findings. Specifically, it was noted that lack of financial resources and
staffing to support such efforts are strong barriers to dissemination.
Scientists stated explicitly, the need to “learn dissemination skills.
Have a dedicated staff to assist with effective dissemination strategies. It is time-consuming and not all scientists are good at this
part, so it would be good to work with creative staff and partners
on this.” Scientists largely agreed that dissemination needs to begin
early in the study design process, but is actually accomplished posthoc, if it is even considered at all. Furthermore, scientists emphasised that dissemination and traditional research activities often
require different skills and hiring staff specifically to support dissemination activities would improve impact. To rectify this, it was
noted to prospectively prioritise dissemination activities, for example, including additional staffing and resources in research budgets.
Further, the need for resources was continually emphasised.
3b) Emerging dissemination channels
Scientists conveyed the need to increase their own use of emerging dissemination channels of reporting research findings. It was suggested to
“create a website with regular blogs, social media posts and press
releases” to share research findings to the non-research community.
It was also recommended to create “visual abstracts for sharing on
social media would likely garner more attention and interest – graphic
design and visuals are very helpful communication tools.”
3c) Identify and address issues of priority for stakeholders
Scientists referenced both practical and logistical challenges to
meeting with stakeholders and the need to partner with them during all phases of the research process, noted that “non-researchers
often do not care about or want to use research, so knowing how to
make them interested in it to begin with would be my silver bullet.”
Specifically, the need to “better understand their [stakeholders]
priorities” was expressed as well as the need to “to develop a formal
dissemination plan as part of the research plan, including stakeholders in this process.” Table 3 presents additional quotes regarding researchers’ recommendations on ways to improve the system.
Discussion
This study provides insights into how D&I scientists work is
assessed in the academic setting with regard to dissemination to
non-research audiences (e.g., practitioners, policymakers). Along
with the recently published companion paper that reported frequency of use of different dissemination strategies, this report
identified important considerations, needs, options and alternatives for both scientists and funding agencies [8]. D&I scientists
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overwhelmingly stated that methods of professional evaluation are
lacking, citing an absence of recognition of dissemination activities
as well as lack of resources for necessary support. In addition, scientists shared their beliefs of what might enhance the dissemination process.
D&I scientists reported a lack of acknowledgement or perceived
importance of dissemination activities (outside of publications and
scientific presentations) in annual or promotional evaluations.
Scientists emphasised the need for funders to require dissemination activities as part of funding announcements and the research
process, which could conceivably lead to greater emphasis on these
activities in both proposals and funded projects. Finally, many scientists called for the creation and promotion of quantifiable metrics which could be applied to evaluating the impact of
dissemination activities in the real-world.
The findings of this study fit into similar contexts of other studies that have explored research perspectives on dissemination.
Tabak et al. conducted a cross-sectional study of 266 public health
researchers at universities, the National Institutes of Health (NIH),
and Centers for Disease Control and Prevention (CDC) [12]. The
study authors compared self-rated effort to disseminate findings to
non-research audiences across predictor variables in three categories: perceptions or reasons to disseminate, perceived expectation
by employer/funders and professional training and experience.
Results found one-third of scientists rated their dissemination
efforts as poor. Many factors were significantly related to whether
a researcher rated him/herself as excellent/good, including obligation to disseminate findings, whether dissemination was important
to their academic department and expectations by grant funders.
Prior studies have also found lack of internal support and expectations by funders [13], as contributing factors to marginal dissemination efforts. However, it is important to note that funders, for
example, the Veteran’s Administration and the PatientCentered Outcomes Research Center (PCORI) have been requiring
a dissemination plan in grant proposals for years.
For scientists, the inclusions of dissemination activities as an
academic measure are an important step that fulfills the requirement of performing “scholarship” [14]. Sharing research findings
with the non-research community is an essential step to decreasing
the 17-year gap that exists in translational science. The experiences
provided indicate a growing awareness of and value for stakeholder
engagement, but few suggestions were made regarding specifically
how to pragmatically and effectively engage stakeholders throughout the research process. Many scientists noted barriers to working
with stakeholders and some proposed the importance of understanding stakeholder priorities and including them in the research
process from inception as a means of improving dissemination
efforts.
The use of a variety of dissemination practices to reach
non-research audiences (e.g., publication, meetings, webinars)
has previously been described by Brownson et al. [7] One challenge
to dissemination in clinical settings is competing priorities among
stakeholders. For scientists, the priority is often on discovery,
rather than application of new knowledge which is frequently
reflected in academic promotional standards. By comparison,
practitioners and policymakers often prioritise practical ways for
applying discoveries for their respective settings [15,16]. This
misalignment of priorities persists, as scientists recently reported
their primary role as identifying effective interventions, not disseminating findings, particularly to non-research stakeholders
[8]. The current study highlights the misalignment of priorities
as it seems researchers prioritise promotional requirements while

https://doi.org/10.1017/cts.2020.563 Published online by Cambridge University Press

5

the academic structure establishes guidelines that may not necessarily consider dissemination of research.
Related to the theme of dissemination metrics, it is important to
note that they do exist. In fact, current perspectives are encouraging
the review of these fields for academic promotion and tenure [17].
Social media has become a critical space for the dissemination of
knowledge and outreach to community and policymakers and also
for the creation of communities of practice. For example, Altmetric
(alternative metrics) have become one of the most commonly utilised metrics to track the impact of research articles across electronic
and social media platforms [18]. Altmetrics are metrics and qualitative data that are complementary to traditional, citation-based
metrics by estimating how many people have been exposed to
and engaged with a deliverable through nontraditional channels
(e.g., news, Twitter).These are intended to understand where and
how a piece of research is being discussed and shared, both among
other scholars, key stakeholders and in the general public, and can
signal that research is changing a field of study or having any other
number of tangible effects upon larger society (e.g., inclusion in a
policy document). These metrics would theoretically help operationalise and streamline the discussion of dissemination activities during
employment and promotion evaluation, incentivising researchers to
devote resources to dissemination.
While these dissemination opportunities do exist, such efforts
are not widespread and consistent, likely due to multiple challenges. For example, the appraisal of the quality and appropriateness of the content, the evaluation of impact on the academe and
general populations, coupled with the creation of a system to
reward scholars engaged in non-research dissemination [18], are
all likely to play some role.
Further, in the case of clinical trials, the SPIRIT guidelines
require a dissemination policy in the research protocol [19].
Specifically, it asks for a plan for investigators and sponsor to communicate trial results to participants, healthcare professionals, the
public and other relevant groups (e.g., via publication, reporting in
results databases or other data sharing arrangements). While the
scientists surveyed in this study may not conduct clinical trials,
it is important to note that SPIRIT requires dissemination as part
of the protocol and can be expanded and modified for the academic
community. The addition of the implications of the findings for
modifications of this widely adapted tool would enhance the relevance to a wider framework of clinical and translational science.
Equally important to the discussion of study results is the
acknowledgement of responses not found. Surprisingly, none of
the scientist mentioned the importance of using theory to guide
dissemination and implementation efforts. It is noteworthy that
scientists did not mention this as part of what is needed to further
disseminate their work, considering “theories guide implementation, facilitate the identification of determinants of implementation, guide the selection of implementation strategies, and
inform all phases of research by helping to frame study questions
and motivate hypotheses, anchor background literature, clarify
constructs to be measured, depict relationships to be tested and
contextualise results (pg.2)” [20].
In recent years, novel disciplines such as quality improvement,
informatics and innovation have endeavoured to redefine the
scope and nature of scholarly work in medical schools: however,
other academic disciplines have lagged [21]. While current literature shows that many academic promotion and tenure committees
in USA have adapted and modified their appraisal systems to
reflect changes in the research environment, though it is not a
common practice recognised across the greater academic milieu.
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Further research is needed to: a) identify ways to address the
themes noted in this study, b) understand how to increase the priority for disseminating study findings to diverse audiences among
D&I researchers, employers and funders and c) test the most effective ways to share results outside of academic settings.

McNeal et al.
Ethics approval and consent to participate. The project was approved by
the Colorado Combined Institutional Review Board (COMIRB), including a
waiver of written consent to participate.
Availability of data and materials. The datasets used and/or analyzed during
the current study are available on the Open Science Framework. More limited
datasets are available under any reasonable data use agreement with the
Principle Investigator (Knoepke).

Limitations and Future Directions
Although informative, this study has several limitations. First, the
survey was conducted online as opposed to the conduction of
in-person interviews or focus groups, which reduced the opportunity to use prompts or to follow up with scientist for additional
information. Second, the scientists sampled primarily specialise
in public health, health services and D&I research, overlooking
basic science researchers which may disseminate differently
(e.g., through the patent process) and experience different academic and grant funding expectations.
Although a number of themes emerged from comments concerning
needs, few specific innovative recommendations or examples emerged
from researchers whose area of expertise is dissemination and implementation. Recommendations for future research and action might
include case reports on the impact of requiring reporting of D&I activities in evaluation of performance and more specific requirements by
funders and sharing and evaluation of different metrics of dissemination to non-research audiences.

Conclusion
Bridging the persistent gap between scientific discovery and application
to real-world policy and practice will require a host of structural changes
to the appointment and promotions guidelines surrounding health
research, as well as to the individual practices of D&I and performance
evaluations [22]. In this project, we summarised perceived need for support from the perspective of D&I scientists, including the need to: 1)
streamline the reporting and quantification of dissemination activities
to non-research audiences for the purpose of employment evaluations,
2) more meaningful integration of dissemination planning into
research at the design and proposal stage and 3) develop skills in dissemination activities outside of academic publications and presentations, including those more likely to reach audiences of practitioners
and policymakers. Future inquiry and documentation of efforts to
implement these recommendations should help reduce the researchtranslation gap.
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